. 2023 Jul 21;24:465. doi: 10.1186/s13063-023-07477-9

Table 3.

Vaccine formulations to be administered in OptImms

Manufacturer	Vaccine	Contents
Serum Institute of India	DTwP-HBV-Hib	Diphtheria toxoid ≥ 30 IU, Tetanus toxoid ≥ 40 IU B. Pertussis (whole cell) ≥ 4 IU, Hep B surface antigen (rDNA) 10mcg, Purified capsular polysaccharide of Hib (PRP) conjugated to tetanus toxoid (carrier protein) 10mcg
Bharat-Biotech	Typhoid conjugate	Purified Vi-capsular polysaccharide of S. Typhi Ty2 conjugated to Tetanus Toxoid 25 µg
Sanofi Pasteur	Yellow fever	Yellow fever virus1 17D-204 strain (live, attenuated) not less than 1000 IU produced in specified pathogen-free chick embryos

Manufacturer

Vaccine

Contents

Serum Institute of India

DTwP-HBV-Hib

Diphtheria toxoid ≥ 30 IU,

Tetanus toxoid ≥ 40 IU

B. Pertussis (whole cell) ≥ 4 IU, Hep B surface antigen (rDNA) 10mcg,

Purified capsular polysaccharide of Hib (PRP)

conjugated to tetanus toxoid (carrier protein) 10mcg

Bharat-Biotech

Typhoid conjugate

Purified Vi-capsular polysaccharide of S. Typhi Ty2 conjugated to Tetanus Toxoid 25 µg

Sanofi Pasteur

Yellow fever

Yellow fever virus1 17D-204 strain (live, attenuated) not less than 1000 IU produced in specified pathogen-free chick embryos